<?xml version="1.0" encoding="utf-8"?><presentation id="2925"><title><![CDATA[S22:  Hyundai Integrates Social Into CRM]]></title><date><![CDATA[10/20/2009 11:15:00 AM]]></date><defaultInterface id="1">Dual Screen</defaultInterface><defaultWindow id="2">RightWindow</defaultWindow><demoStartPoint>0</demoStartPoint><demoLength>300</demoLength><allowNavigation>True</allowNavigation><duration>3144600</duration><forwardLink type="-1"><![CDATA[]]></forwardLink><ratingAverage><![CDATA[1.00]]></ratingAverage><totalRatings><![CDATA[1]]></totalRatings><sponsorZoneId><![CDATA[-1]]></sponsorZoneId><viewer id="10290"><firstName><![CDATA[John]]></firstName><middleName><![CDATA[p]]></middleName><lastName><![CDATA[Demo2]]></lastName><title><![CDATA[CMC Tester]]></title><organization><![CDATA[CONTENT MC]]></organization><email><![CDATA[demo@cmcgc.com]]></email><userName><![CDATA[demo@cmcgc.com]]></userName><notes><![CDATA[testing]]></notes><rating><![CDATA[-1]]></rating></viewer><media><master><item id="99564"><files><file id="101584" fileType="mp3" quality="Low"><![CDATA[http://www.cmcgc.com/Media/Synch/291018/760/760.mp3]]></file></files><window id="0"><![CDATA[No Window]]></window><startPoint>0</startPoint><link type="-1"><![CDATA[]]></link></item></master><items><item id="101428" inTOC="True"><title><![CDATA[S22: Hyundai Integrates Social Into CRM]]></title><files><file id="104347" fileType="jpg" quality="Low"><![CDATA[http://www.cmcgc.com/Media/Synch/291018/760/Slide1.jpg]]></file></files><window id="2"><![CDATA[RightWindow]]></window><startPoint>0</startPoint><link type="-1"><![CDATA[]]></link></item></items></media><transcript /><speakers />
  <agreements>
    <agreement id="29">
      <name><![CDATA[Player Presentation Agreement]]></name>
      <text>
        <![CDATA[<p><b>ASN  Renal WeekEnds 2011 Online</b></p>
<p><b>Course</b><b> Description</b><br>
  Renal  WeekEnds 2011 provides a comprehensive overview of Renal Week 2010. The  fundamental aspects of the basic sciences that have potential for future  integration into clinical medicine are presented alongside translational  research and novel clinical breakthroughs in renal medicine. Six disciplines of  nephrology are presented by respective experts in this format: acute kidney  injury, kidney transplantation, hypertension, end-stage renal disease,  glomerular disorders, and clinical nephrology. State-of-the-art information is  cogently gauged against the prevailing body of knowledge, in evidence-based  fashion, and summarized succinctly. A personalized Q &amp; A session with the  faculty melds these intellectual discussions with the practicing nephrologist.</p>
<p><b><u>Original Release Date</u></b><br>
  May 2011</p>
<p><b><u>Termination Date</u></b><br>
  January 31, 2012</p>
<p><b><u>Estimated  time to complete RWE Online </u></b><br>
  9 hours</p>
<p><b><u>Accreditation</u></b><br>
  ASN is accredited by the Accreditation  Council for Continuing Medical Education to provide continuing medical  education for physicians.</p>
<p>ASN designates this enduring educational  activity for a maximum of 9 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians  should only claim credit commensurate with the extent of their participation in  the activity.</p>
<p>Upon completion of the online attestation and evaluation,  CME credit will be posted to your ASN transcript right away.&nbsp; </p>
<p><b><u>Learning Objectives</u></b><br>
  At  the end of this activity, the participant will be able to:</p>
<ul>
  <li>Identify  new discoveries and forefronts in basic science that have potential importance  in nephrology.</li>
  <li>Comprehend  novel translational medical therapies that apply to future practice.</li>
  <li>Construct  relevant clinical research questions based upon the materials presented.</li>
  <li>Delineate  best practices based on quality of evidence that may be used in the learner's  practice.</li>
  <li>Determine  those clinical advances in hypertension, acute kidney injury, transplantation,  end-stage renal disease, parenchymal disorders, and clinical nephrology that  are transferable to daily practice.</li>
</ul>
<p><b><u>Target Audience</u></b><br>
  Physicians<br>
  Researchers<br>
  Physicians-in-Training<br>
  Other Health Professionals</p>
<p><b><u>Course Faculty List</u></b><br>
  Faculty at ASN  Renal WeekEnds dissects and clarifies key presentations from ASN Renal Week  2010 in Denver, Colorado.&nbsp; <br>
  <b>Anupam Agarwal, MD,  FASN</b><br>
  University of Alabama at Birmingham<br>
  Birmingham, AL</p>
<p><b>Mary Tessie  Behrens, MD, FASN</b><br>
  Mid-Atlantic Nephrology Associates, PA<br>
  Catonsville, MD</p>
<p><b>Anatole Besarab, MD</b><br>
  Henry Ford Hospital<br>
  Detroit, MI</p>
<p><b>Michael J. Choi, MD</b><br>
  Johns Hopkins University<br>
  School of Medicine<br>
  Baltimore, MD</p>
<p><b>Michel B. Chonchol,  MD</b><br>
  University of Colorado Denver<br>
  Health Sciences Center<br>
  Denver, CO</p>
<p><b>Maria V. DeVita, MD</b><br>
  Lenox Hill Hospital<br>
  New York, NY</p>
<p><b>Andrew Z. Fenves,  MD, FASN</b><br>
  Dallas Nephrology Associates<br>
  Dallas, TX</p>
<p><b>John S. Gill, MD</b><br>
  St. Paul's Hospital<br>
  University of British Columbia<br>
  Burnaby, Canada</p>
<p><b>David S. Goldfarb,  MD, FASN</b><br>
  New York Harbor VAMC<br>
  New York, New York</p>
<p><b>Karen A. Griffin,  MD, FASN</b><br>
  Loyola University Medical Center,<br>
  Hines VA Hospital<br>
  Maywood, IL</p>
<p><b>Benjamin D.  Humphreys, MD, PhD, FASN</b><br>
  Brigham and Women's Hospital<br>
  Boston, MA</p>
<p><b>James P. Lash, MD,  FASN</b><br>
  University of Illinois Hospital<br>
  Chicago, IL</p>
<p><b>Charmaine E. Lok,  MD</b><br>
  University Health Network &ndash;<br>
  Toronto General Hospital<br>
  Toronto, Canada</p>
<p><b>Roslyn B. Mannon,  MD, FASN</b><br>
  University of Alabama at Birmingham<br>
  Birmingham, AL</p>
<p><b>Louise M. Moist, MD</b><br>
  London Health Sciences Centre<br>
  London, Canada<br>
  <b>Barbara T. Murphy,  MD</b><br>
  Mount Sinai Medical Center<br>
  New York, NY</p>
<p><b>Patrick H. Nachman,  MD, FASN</b><br>
  University of North Carolina at Chapel Hill<br>
  Chapel Hill, NC</p>
<p><b>Mark D. Okusa, MD,  FASN</b><br>
  University of Virginia<br>
  Health System<br>
  Charlottesville, VA</p>
<p><b>Aldo J. Peixoto,  MD, FASN</b><br>
  VA Connecticut Healthcare System<br>
  West Haven, CT</p>
<p><b>Jai Radhakrishnan,  MD, FASN</b><br>
  Columbia University<br>
  New York, NY</p>
<p><b>Dominic S. Raj, MD,  FASN</b><br>
  George Washington University<br>
  Washington, DC</p>
<p><b>Brad H. Rovin, MD,  FASN</b><br>
  Ohio State University Medical Center<br>
  Columbus, OH</p>
<p><b>Robert D. Toto, MD</b><br>
  University of Texas Southwestern<br>
  Medical Center<br>
  Dallas, TX</p>
<p><b>Miguel A. Vazquez,  MD</b><br>
  University of Texas Southwestern<br>
  Medical Center<br>
  Dallas, TX</p>
<p><b>Matthew R. Weir, MD</b><br>
  University of Maryland Hospital<br>
  Baltimore, MD</p>
<p><b>Jerry Yee, MD, FASN</b><br>
  Henry Ford Hospital<br>
  Detroit,  MI</p>
<p><b><u>Disclosure Statement</u></b><br>
  It is the policy of the American Society of  Nephrology (ASN) that all individuals in a position to control the 
  content of ASN&rsquo;s sponsored CME activities are  expected to provide full disclosure for both themselves<br>
  and their spouse/partner, and to indicate to the  activity audience any financial or other relationship held 
  by themselves or their spouse/partner 1) with the  manufacturer(s) of any commercial product(s) and/or<br>
  provider(s) of commercial service(s) discussed in an  educational presentation; and 2) with any 
  commercial supporter(s) of the activity. All  responses should reflect activities within the previous 12<br>
  months. This disclosure information is collected in  accordance with Accreditation Council for Continuing 
  Medical Education (ACCME). Furthermore, ASN requests  all faculty to disclose at the time of their<br>
  lecture any planned discussion of investigational  and/or off-label use of pharmaceutical products or 
  devices within their presentation. Participants  should note that the use of products outside U.S. Food<br>
  and Drug Administration (FDA) approved labeling  should be considered experimental and are advised to 
  consult current prescribing information for approval  indications. The intent of this policy is not to prevent<br>
  expert faculty with relevant relationship(s) with  commercial interest(s) from involvement in Continuing 
  Medical Education (CME), but rather to ensure that  ASN CME activities promote quality and safety, are<br>
  effective in improving medical practice, are based  on valid content, and are independent of control from 
  commercial interests and free of commercial bias. In  addition, all faculty members were instructed to<br>
  provide balanced, scientifically rigorous, and  evidence-based presentations.   </p>
<p> ASN requires all individuals in a position to  control content for ASN Renal WeekEnds 2011 to complete 
  disclosure forms. Responses are listed on the  following pages which is available to each meeting<br>
  participant.<br>
  <b>Anupam Agarwal, MD,  FASN</b> &ndash; <em>Scientific  Advisor or Membership</em>: Genzyme Renal Innovations Program 
  Review Panel, Complexa.<br>
  <b>Mary Tessie  Behrens, MD, FASN</b> &ndash; <em>Scientific Advisor</em>: NKF (Maryland's Board of Directors); <em>Other</em> <em>Relationship</em>: DaVita (Joint Venture in  Dialysis Unit).<br>
  <b>Anatole Besarab, MD</b> - <em>Ownership: </em>Vasc Alert; <em>Consultancy: </em>Amgen, Hoffman-La Roche, Akebia, 
  Affymax, Rockwell International; <em>Research  Funding: </em>Abbott, Roche, Fibrogen, Luitpold; <em>Honoraria:</em><br>
  Affymax, Amgen, ASN, Ash Access Technology,  Bioconnect, Fallon Medica, FMC, Genentech, 
  HemoSphere, Hoffman-LaRoche, Hospira, Indiana Univ,  John Hopkins Univ, Luitpold Pharm, Merck,<br>
  NKF, NKF of Michigan, NKF of Georgia, New York Soc  of Nephrology, Quintiles, Renal Advantage, 
  Rockwell Medical, Scientific Consulting Group (NIH),  Soc of Nephrology of Puerto Rico, Speedel, St.<br>
  Michael's Hosp (Toronto), St. John's Hosp (Detroit),  Takeda, Univ of Cincinatti, Univ of Miami, Univ of 
  Missouri, VascAlert, Walter Kluger (Publisher),  Winthrop Univ, Watson Pharma; <em>Scientific Advisor:</em><br>
  Amgen, Affymax, Akebia, Rockwell International.<br>
  <b>Michael J. Choi, MD</b> - <em>Research Funding: </em>Otsuka; <em>Honoraria: </em>ASN Renal WeekEnds (Co-chair for 
  Washington DC &amp; Speaker), Clinical Nephrology  Mid Atlantic Young Investigator's Forum (Co-chair);<br>
  <em>Scientific Advisor: </em>Advances in Chronic Kidney  Diseases (Deputy Editor), NKF KDOQI (Education 
  Committee Vice-Chair).<br>
  <b>Michel B. Chonchol</b>, <b>MD</b> &ndash; Nothing to disclose.<br>
  <b>Maria V. DeVita, MD</b> &ndash; <em>Consultancy</em>: Forrest Pharma; <em>Honoraria: </em>Forrest Pharma.<br>
  <b>Arthur Z. Fenves,  MD, FASN</b> &ndash; <em>Honoraria: </em>Novartis (Speaker&rsquo;s Bureau); <em>Scientific Advisor: </em>Dialysis &amp; 
  Transplantation (Co-editor), Wiley- Blackwell; <em>Other  Relationship: </em>UpToDate (Royalties).<br>
  <b>John S. Gill, MD</b> &ndash; Nothing to disclose.<br>
  <b>David S. Goldfarb,  MD, FASN</b> &ndash; <em>Ownership</em>:  Ravine Group; <em>Consultancy</em>: Takeda, Watson; <em>Research</em> <em>Funding</em>: Amgen, Kibow; <em>Honoraria</em>:  Genzyme.<br>
  <b>Karen A. Griffin,  MD, FASN</b> &ndash;  Nothing to disclose.<br>
  <b>Benjamin D.  Humphreys, MD, PhD, FASN</b> - <em>Ownership: </em>SurfaceLogix; <em>Consultancy: </em>SurfaceLogix, 
  AstraZeneca, PGxHealth (Adenosine Therapeutics,  LLC); <em>Research Funding: </em>Genzyme, PGxHealth<br>
  (Adenosine Therapeutics, LLC); <em>Honoraria: </em>Sanofi-Aventis,  Novartis; <em>Patents and Inventions</em>: PGxHealth 
  (Adenosine Therapeutics, LLC).<br>
  <b>James P. Lash, MD,  FASN</b> &ndash; Nothing  to disclose.<br>
  <b>Charmaine E. Lok,  MD</b> &ndash; Nothing to  disclose.<br>
  <b>Roslyn B. Mannon,  MD, FASN</b> &ndash; <em>Consultancy: </em>Amgen; <em>Research Funding: </em>Amgen; <em>Honoraria: </em>AST,
  ASN, Biogen (Spouse).<br>
  <b>Louise M. Moist, MD</b> &ndash; Nothing to disclose.<br>
  <b>Barbara T. Murphy,  MD</b> &ndash; Nothing to  disclose.<br>
  <b>Patrick T. Nachman,  MD, FASN</b> &ndash;  Nothing to disclose.<br>
  <b>Mark D. Okusa, MD,  FASN</b> &ndash; <em>Research  Funding: </em>Genzyme (GrIp Award); <em>Patent: </em>Royalties from Sale of
  Adenosine Therapeutics (Now PGx Health).<br>
  Aldo J. Peixoto, MD, FASN &ndash; <em>Consultancy: </em>Abbott,  Sanofi-Aventis; <em>Research Funding: </em>Pulsemetric;  <em>Honoraria: </em>Boehringer Ingelheim; <em>Scientific  Advisor: </em>Blood Pressure Monitoring (Assoc Editor).<br>
  <b>Jai Radhakrisknan,  MD, FASN</b> &ndash; <em>Research  Funding: </em>Otsuka; <em>Scientific Advisor: </em>Genentech, Otsuka.<br>
  <b>Dominic S. Raj, MD,  FASN</b> &ndash; Nothing  to disclose.<br>
  <b>Brad H. Rovin, MD,  FASN</b> &ndash; <em>Scientific  Advisor: </em>Questcor, Centocor, Genentech, Osprey, Glaxo.<br>
  <b>Robert D. Toto, MD</b> &ndash; <em>Consultancy: </em>Amgen; <em>Honoraria: </em>Amgen; <em>Scientific Advisor: </em>Amgen.<br>
  <b>Miguel A. Vazquez,  MD</b> &ndash; <em>Research  Funding</em>: Amgen<br>
  <b>Matthew R. Weir, MD</b> &ndash; <em>Honoraria</em>: Amgen,  Nicox, Novartis, Daiichi Sankyo; <em>Scientific Advisor</em>: Amgen,
  Nicox, Novartis, Daiichi Sankyo.<br>
  <b>Jerry Yee, MD, FASN</b> &ndash; <em>Employer</em>: Henry Ford  Health System; <em>Ownership</em>: Merck; <em>Consultancy</em>: Amgen,
  Affymax, Takeda, Merck, AMAG, Watson; <em>Research  Funding</em>: Fresenius; <em>Honoraria</em>: Amgen, Affymax,
  Takeda, Merck, AMAG, Watson, Genzyme; <em>Scientific  Advisor</em>: Amer Journal of Nephrology (Editorial
  Staff); Advances in Chronic Kidney Disease  (Editor-in-Chief); <em>Patent</em>: Vasc-Alert; <em>Other Relationship</em>:  Coinventor
  of Regional Citrate Anticoagulation Technology  (Patent Pending), Author of CKD Book (With
  Copyright by Henry Ford Health System).<br>
  <b>ASN Staff</b><br>
  The following American Society of Nephrology (ASN)  staff has nothing to disclose:<br>
  Kara Davis<br>
  Cara Hill<br>
  Angela Kim<br>
  Jin Soo Kim<br>
  Phillip Kokemueller<br>
  Ryan Russell<br>
Alisha  Workman</p>
<p>View  the full ASN <a href="http://www.asn-online.org/cme/" target="_blank"><b>Conflict of  Interest and Disclosure Policy</b></a>.</p>
<p><b><u>Hardware/Software Requirements</u></b><br>
    <b>Computers </b><br>
  Any computer running Windows, Mac OS, or Unix machines are supported. </p>
<p><b>System  Requirements</b><br>
  For  a successful viewing experience, the following hardware and software are  required:</p>
<ul>
  <li>Broadband cable,  DSL or high-speed Internet connection</li>
  <li>Internet Explorer  version 7 or higher or equivalent modern browser </li>
  <li>533 MHz or faster  processor</li>
  <li>At least 512 MB  RAM</li>
  <li>Adobe Reader 10</li>
  <li>Adobe Flash  Player v. 9 or higher</li>
</ul>
<p><b><u>Method of Participation</u></b></p>
<ul type="disc">
  <li>Listen       and view the streaming media with slides.</li>
  <li>Complete       the CME evaluation.</li>
</ul>
<p><b><u>Medium  or Combination of Media Used</u></b></p>
<ul>
  <li>Streaming media of slides with audio<b></b></li>
</ul>
<p><b><u>Fees</u></b><br>
  ASN Member = $275<br>
  ASN  Fellow-in-Training (Nephrology) = $50<br>
  Nonmember = $350</p>
<p><b><u>Refund Policy</u></b><br>
  All sales are  final.</p>
<p><b><u>RWE 2011 Live Activity Participants</u></b><br>
  If you previously completed and received credit for the live CME activity, <em>Renal WeekEnds 2011</em>, please note that  you will not receive credit for completing this activity.<br>
  <b><u>Renal WeekEnds Support</u></b><br>
  ASN thanks the following companies  for their support of Renal WeekEnds 2011:<br>
  <a href="http://www.amgen.com/" target="_blank"><img border="0" width="170" height="43" src="http://asn.sclivelearningcenter.com/Support/174/amgen.jpg" alt="Amgen"></a><br>
  <br>
  <a href="http://www.bms.com/" target="_blank"><img border="0" width="216" height="43" src="http://asn.sclivelearningcenter.com/Support/174/Bristol.jpg" alt="Bristol-Myers Squibb"></a>&nbsp;&nbsp;&nbsp; <br>
  <br>
  <a href="http://www.merck.com/" target="_blank"><img border="0" width="180" height="53" src="http://asn.sclivelearningcenter.com/Support/174/Merck.jpg" alt="Merck"></a> </p>
<p><a href="http://www.reatapharma.com/" target="_blank"><img border="0" width="210" height="53" src="http://asn.sclivelearningcenter.com/Support/174/REATA.jpg" alt="Reata"></a><b><u> </u></b></p>
<p><b><u>&nbsp;</u></b></p>
<p><b><u>Privacy Policy/Confidentiality </u></b> <br>
  As a condition of your access and use of the Website, you  agree not to use the Website for any purpose that is unlawful or inconsistent  with the Agreement. ASN, in its sole discretion, is authorized to remove or  delete any entries, information, materials, or other content that violates  these Terms of Use or that is otherwise objectionable. ASN reserves the right  to investigate and prosecute violations of any of these Terms of Use to the fullest  extent of the law. If Users fail to comply with these Terms of Use, ASN in its  sole discretion may terminate the User&rsquo;s access to the website immediately  without advance notice. These terms of use comprise an Agreement that is  governed by the laws of the District of Columbia, which shall be the forum for  any disputes.<b><u> </u></b></p>
<p><b><u>ASN Medical Disclaimer</u></b><br>
  The American Society of Nephrology  (&quot;ASN&quot;) does not offer medical advice. All content in ASN  publications, including this website, is for informational purposes only, and  is not intended to cover all possible uses, directions, precautions, drug  interactions, or adverse effects. This content should not be used during a  medical emergency or for the diagnosis or treatment of any medical condition.  Please consult your doctor or other qualified health care provider if you have  any questions about a medical condition, or before taking any drug, changing  your diet or commencing or discontinuing any course of treatment. Do not ignore  or delay obtaining professional medical advice because of information accessed  through ASN. Call 911 or your doctor for all medical emergencies.<br>
  <b><u>Contact Information</u></b><br>
  For any questions  concerning this activity, please contact ASN at 202-659-0599 or via email to <a href="mailto:email@asn-online.org"><b>email@asn-online.org</b></a>. </p>
<p>&nbsp;</p>]]>
      </text>
      <acceptText><![CDATA[I Accept]]></acceptText>
      <acceptLink><![CDATA[]]></acceptLink>
      <declineText><![CDATA[I Decline]]></declineText>
      <declineLink><![CDATA[redirector.aspx?SPID=1844]]></declineLink>
    </agreement>
  </agreements><bookmarks><bookmark id="58"><title><![CDATA[S22: Hyundai Integrates Social Into CRM]]></title><startPoint>0</startPoint></bookmark></bookmarks></presentation>